Frail elderly patients with relapsed-refractory multiple myeloma: efficacy and toxicity profile of the combination of bortezomib, high-dose dexamethasone, and low-dose oral cyclophosphamide

被引：12
|
作者：
Mele, Giuseppe [1 ]
Giannotta, Angela
Pinna, Salvatore
Loseto, Giacomo
Coppi, Maria Rosaria
Brocca, Claudio Maurizio
Melpignano, Angela
Quarta, Giovanni
机构：
[1] Antonio Perrino Hosp, Clin Div Hematol, I-72100 Brindisi, Italy
来源：
LEUKEMIA & LYMPHOMA | 2010年 / 51卷 / 05期
关键词：
PREDNISONE PLUS THALIDOMIDE; MELPHALAN;
D O I：
10.3109/10428191003695660
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：937 / 940
页数：4
相关论文
共 50 条
  • [1] Bortezomib in combination with high-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.
    Kropff, M
    Bisping, G
    Liebisch, P
    Sezer, O
    Einsele, H
    Straka, C
    Kroeger, N
    Metzner, B
    Engelhardt, M
    Lang, N
    Hentrich, M
    Wolf, H
    von Schilling, C
    Salwender, H
    Berdel, WE
    Kienast, J
    BLOOD, 2005, 106 (11) : 716A - 716A
  • [2] Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma
    Kropff, Martin
    Bisping, Guido
    Schuck, Elke
    Liebisch, Peter
    Lang, Nicola
    Hentrich, Markus
    Dechow, Tobias
    Kroeger, Nicolaus
    Salwender, Hans
    Metzner, Bernd
    Sezer, Orhan
    Engelhardt, Monika
    Wolf, Hans-Heinrich
    Einsele, Hermann
    Volpert, Sarah
    Heinecke, Achim
    Berdel, Wolfgang E.
    Kienast, Joachim
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (03) : 330 - 337
  • [3] Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma
    Azarm, Taleb
    Akbari, Mojtaba
    Azarm, Arezo
    Mohager, Hamid
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (01): : 8 - 14
  • [4] Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma
    Ailawadhi, Sikander
    Sexton, Rachael
    Lentzsch, Suzanne
    Abidi, Muneer H.
    Voorhees, Peter M.
    Cohen, Adam D.
    Rohren, Eric M.
    Heitner, Stephen
    Kelly, Kevin
    Mackler, Niklas J.
    Baer, David M.
    Hoering, Antje
    Durie, Brian
    Orlowski, Robert Z.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 3969 - 3978
  • [5] Low-dose lenalidomide and dexamethasone combination treatment in elderly patients with relapsed and refractory multiple myeloma
    Wang, Chunling
    He, Zhengmei
    Shi, Yuye
    Zhang, Lijuan
    Chen, Yue
    Chen, Zhi
    Yu, Liang
    HEMATOLOGY, 2017, 22 (02) : 88 - 92
  • [6] Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma
    Bahlis, Nizar J.
    Sutherland, Heather
    White, Darrell
    Sebag, Michael
    Lentzsch, Suzanne
    Kotb, Rami
    Venner, Christopher P.
    Gasparetto, Cristina
    Del Col, Aldo
    Neri, Paola
    Reece, Donna
    Kauffman, Michael
    Shacham, Sharon
    Unger, T. J.
    Jeha, Jacqueline
    Saint-Martin, Jean-Richard
    Shah, Jatin
    Chen, Christine
    BLOOD, 2018, 132 (24) : 2546 - 2554
  • [7] Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study
    Martin Kropff
    Martin Vogel
    Guido Bisping
    Rudolf Schlag
    Rudolf Weide
    Wolfgang Knauf
    Heinrich Fiechtner
    Georgi Kojouharoff
    Stephan Kremers
    Wolfgang E. Berdel
    Annals of Hematology, 2017, 96 : 1857 - 1866
  • [8] Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study
    Kropff, Martin
    Vogel, Martin
    Bisping, Guido
    Schlag, Rudolf
    Weide, Rudolf
    Knauf, Wolfgang
    Fiechtner, Heinrich
    Kojouharoff, Georgi
    Kremers, Stephan
    Berdel, Wolfgang E.
    ANNALS OF HEMATOLOGY, 2017, 96 (11) : 1857 - 1866
  • [9] Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
    Richardson, PG
    Sonneveld, P
    Schuster, MW
    Irwin, D
    Stadtmauer, EA
    Facon, T
    Harousseau, JL
    Ben-Yehuda, D
    Lonial, S
    Goldschmidt, H
    Reece, D
    San-Miguel, JF
    Bladé, J
    Boccadoro, M
    Cavenagh, J
    Dalton, WS
    Boral, AL
    Esseltine, DL
    Porter, JB
    Schenkein, D
    Anderson, KC
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (24): : 2487 - 2498
  • [10] Elotuzumab in Combination With Lenalidomide and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
    Lonial, Sagar
    Vij, Ravi
    Harousseau, Jean-Luc
    Facon, Thierry
    Moreau, Philippe
    Mazumder, Amitabha
    Kaufman, Jonathan L.
    Leleu, Xavier
    Tsao, L. Claire
    Westland, Christopher
    Singhal, Anil K.
    Jagannath, Sundar
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) : 1953 - 1959
12345